Contact
Please use this form to send email to PR contact of this press release:
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Cocrystal Pharma, Inc. (Nasdaq: COCP), f/k/a/ BioZone Pharmaceuticals, Inc., To Contact Brower Piven Before The Lead Plaintiff Deadline In…
TO: